共0篇 平均IF=NaN (-)更多分析

    加载中

    logo
    Allogeneic Dentin Graft: A Review on Its Osteoinductivity and Antigenicity. Um In-Woong,Lee Jeong-Keun,Kim Jun-Young,Kim Yu-Mi,Bakhshalian Neema,Jeong Yeong Kon,Ku Jeong-Kui Materials (Basel, Switzerland) Studies on allogeneic demineralized dentin matrix (Allo-DDM) implantation in the 1960s and 1970s provided the most reliable preclinical evidence of bone formation and antigenicity in an extraosseous site. Recently, applications of Allo-DDM at skeletal sites were studied, and have provided reliable evidence of bone-forming capacity and negligible antigenicity. However, the osteoinductivity and antigenicity properties of Allo-DDM in extraskeletal sites have not yet been investigated due to the lack of follow-up studies after the initial research. The clinical applications of autogenous DDM (Auto-DDM) have been standardized in some countries. Long-term clinical studies have reported the development of several shapes of Auto-DDM, such as powders, blocks, moldable forms, and composites, with recombinant human bone morphogenetic protein-2. For the development of Allo-DDM as a reliable bone graft substitute next to Auto-DDM, we reviewed preclinical studies on the bone induction capacity of allogeneic dentin at extraskeletal as well as skeletal sites. Electronic databases were screened for this review in January 2020 and searched from 1960 to 2019. This review aims to provide a foundation on the preclinical studies of Allo-DDM, which could enable future researches on its osteogenic capability and antigenicity. In conclusion, Allo-DDM showed great potential for osteoinductivity in extraskeletal sites with low antigenicity, which neither adversely affected osteogenic capability nor provoked immunologic reactions. However, the risk of viral disease transmission should be researched before the clinical application of Allo-DDM. 10.3390/ma14071713
    Clinical application of autogenous demineralized dentin matrix loaded with recombinant human bone morphogenetic-2 for socket preservation: A case series. Um In-Woong,Kim Young-Kyun,Park Joo-Cheol,Lee Jong-Ho Clinical implant dentistry and related research BACKGROUND:Demineralized dentin matrix (DDM) has potential application as a carrier for recombinant human bone morphogenetic protein-2 (rhBMP-2) in bone regeneration. PURPOSE:To evaluate the efficacy of DDM loaded with rhBMP-2 for socket preservation. MATERIALS AND METHODS:DDM loaded with rhBMP-2 (DDM/rhBMP-2) was applied to 10 experimental sites and DDM alone to 6 control sites. The changes in height and width of the extraction socket after preservation were measured by cone beam computed tomography. Trephine cores were harvested for histomorphometric evaluation before placement of the implant. RESULTS:The reductions in height and width of the socket were more significant in the group treated with DDM than in the group treated with DDM/rhBMP-2. The amount of new bone formation was 34.39% with DDM/rhBMP-2 and 29.75% with DDM; the respective amounts of residual dentin were 8.35% and 16.15%. Although the differences were not statistically significant, the dimensional changes, amount of bone formation, and replacement of DDM in DDM/rhBMP-2 with bone were superior to those of DDM alone. CONCLUSIONS:Within the limitations of this study, we suggest that DDM may be a potential carrier for rhBMP-2 and that it may be possible to reduce the rhBMP-2 concentration to 0.2 mg/mL. 10.1111/cid.12710